Animal models of bronchopulmonary dysplasia. The preterm and term rabbit models

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 307, Issue 12, 2014, Pages L959-L969

  D’Angio, Carl T ^a   Ryan, Rita M ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Bronchopulmonary dysplasia; Hyperoxia; Newborn; Premature; Rabbit

Indexed keywords

CXCL2 CHEMOKINE; CYCLINE; INTERLEUKIN 1BETA; INTERLEUKIN 8; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; SURFACTANT PROTEIN A; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

COMPARATIVE STUDY; DISEASE COURSE; HYPEROXIA; INFLAMMATION; LUNG DISEASE; LUNG DYSPLASIA; LUNG FIBROSIS; LUNG FUNCTION; LUNG INJURY; MALNUTRITION; NEWBORN INFECTION; NONHUMAN; PREMATURITY; RABBIT MODEL; REVIEW; ANIMAL; DISEASE MODEL; FEMALE; HUMAN; METABOLISM; NEWBORN; PATHOLOGY; PATHOPHYSIOLOGY; PREGNANCY; RABBIT;

ANIMALS; ANIMALS, NEWBORN; BRONCHOPULMONARY DYSPLASIA; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; HYPEROXIA; INFLAMMATION; PREGNANCY; PREMATURE BIRTH; RABBITS;

EID: 84918547648     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00228.2014     Document Type: Review

References (126)

1. Ahmed MN, Codipilly C, Hogg N, Auten RL. The protective effect of overexpression of extracellular superoxide dismutase on nitric oxide bioavailability in the lung after exposure to hyperoxia stress. Exp Lung Res 37: 10–17, 2011.
2. Ahmed MN, Suliman HB, Folz RJ, Nozik-Grayck E, Golson ML, Mason SN, Auten RL. Extracellular superoxide dismutase protects lung development in hyperoxia-exposed newborn mice. Am J Respir Crit Care Med 167: 400–405, 2003.
3. Albertine KH. Progress in understanding the pathogenesis of BPD using the baboon and sheep models. Semin Perinatol 37: 60–68, 2013.
4. Alcorn DG, Adamson TM, Maloney JE, Robinson PM. A morphologic and morphometric analysis of fetal lung development in the sheep. Anat Rec 201: 655–667, 1981.
5. Ambalavanan N, Carlo WA, D’Angio CT, McDonald SA, Das A, Schendel D, Thorsen P, Higgins RD; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123: 1132–1141, 2009.
6. Aprille JR, Rulfs J. Dietary lipid and postnatal development. I. A model for neonatal studies requiring high and low fat diets from birth. Pediatr Res 10: 978–981, 1976.
7. Asikainen TM, Ahmad A, Schneider BK, White CW. Effect of preterm birth on hypoxia-inducible factors and vascular endothelial growth factor in primate lungs. Pediatr Pulmonol 40: 538–546, 2005.
8. Balasubramaniam V, Mervis CF, Maxey AM, Markham NE, Abman SH. Hyperoxia reduces bone marrow, circulating, and lung endothelial progenitor cells in the developing lung: implications for the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 292: L1073–L1084, 2007.
9. Bany-Mohammed FM, Slivka S, Hallman M. Recombinant human erythropoietin: possible role as an antioxidant in premature rabbits. Pediatr Res 40: 381–387, 1996.
10. Bhandari V, Choo-Wing R, Lee CG, Yusuf K, Nedrelow JH, Ambalavanan N, Malkus H, Homer RJ, Elias JA. Developmental regulation of NO-mediated VEGF-induced effects in the lung. Am J Respir Cell Mol Biol 39: 420–430, 2008.
11. Bhatt AJ, Pryhuber GS, Huyck H, Watkins RH, Metlay LA, Maniscalco WM. Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia. Am J Respir Crit Care Med 164: 1971-1980, 2001.
12. Bland RD, Xu L, Ertsey R, Rabinovitch M, Albertine KH, Wynn KA, Kumar VH, Ryan RM, Swartz DD, Csiszar K, Fong KS. Dysregulation of pulmonary elastin synthesis and assembly in preterm lambs with chronic lung disease. Am J Physiol Lung Cell Mol Physiol 292: L1370-L1384, 2007.
13. Bonikos DS, Bensch KG, Northway WH Jr. Oxygen toxicity in the newborn. The effect of chronic continuous 100 percent oxygen exposure on the lungs of newborn mice. Am J Pathol 85: 623–650, 1976.
14. Brunelli L, Hamilton E, Davis JM, Koo HC, Joseph A, Kazzaz JA, Wolfson MR, Shaffer TH. Perfluorochemical liquids enhance delivery of superoxide dismutase to the lungs of juvenile rabbits. Pediatr Res 60: 65–70, 2006.
15. Bucher JR, Roberts RJ. The development of the newborn rat lung in hyperoxia: a dose-response study of lung growth, maturation, and changes in antioxidant enzyme activities. Pediatr Res 15: 999–1008, 1981.
16. Buczynski BW, Maduekwe ET, O’Reilly MA. The role of hyperoxia in the pathogenesis of experimental BPD. Semin Perinatol 37: 69–78, 2013.
17. Burri PH, Dbaly J, Weibel ER. The postnatal growth of the rat lung. I. Morphometry. Anat Rec 178: 711–730, 1974.
18. Chang YS, Choi SJ, Sung DK, Kim SY, Oh W, Yang YS, Park WS. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Cell Transplant 20: 1843–1854, 2011.
19. Charafeddine L, D’Angio CT, Phelps DL. Atypical chronic lung disease patterns in neonates. Pediatrics 103: 759–765, 1999.
20. Charafeddine L, D’Angio CT, Richards JL, Stripp BR, Finkelstein JN, Orlowski CC, LoMonaco MB, Paxhia A, Ryan RM. Hyperoxia increases keratinocyte growth factor mRNA expression in neonatal rabbit lung. Am J Physiol Lung Cell Mol Physiol 276: L105–L113, 1999.
21. Chess PR, D’Angio CT, Pryhuber GS, Maniscalco WM. Pathogenesis of bronchopulmonary dysplasia. Semin Perinatol 30: 171–178, 2006.
22. Chua CO, Vinukonda G, Hu F, Labinskyy N, Zia MT, Pinto J, Csiszar A, Ungvari Z, Ballabh P. Effect of hyperoxic resuscitation on propensity of germinal matrix haemorrhage and cerebral injury. Neuropathol Appl Neurobiol 36: 448–458, 2010.
23. Coalson JJ, Winter VT, Siler-Khodr T, Yoder BA. Neonatal chronic lung disease in extremely immature baboons. Am J Respir Crit Care Med 160: 1333–1346, 1999.
24. Curstedt T, Johansson J. Different effects of surfactant proteins B and C-implications for development of synthetic surfactants. Neonatology 97: 367–372, 2010.
25. D’Angio CT, Basavegowda K, Avissar NE, Finkelstein JN, Sinkin RA. Comparison of tracheal aspirate and bronchoalveolar lavage specimens from premature infants. Biol Neonate 82: 145–149, 2002.
26. D’Angio CT, Finkelstein JN, Lomonaco MB, Paxhia A, Wright SA, Baggs RB, Notter RH, Ryan RM. Changes in surfactant protein gene expression in a neonatal rabbit model of hyperoxia-induced fibrosis. Am J Physiol Lung Cell Mol Physiol 272: L720–L730, 1997.
27. D’Angio CT, LoMonaco MB, Chaudhry SA, Paxhia A, Ryan RM. Discordant pulmonary proinflammatory cytokine expression during acute hyperoxia in the newborn rabbit. Exp Lung Res 25: 443–465, 1999.
28. D’Angio CT, Maniscalco WM. The role of vascular growth factors in hyperoxia-induced injury to the developing lung. Front Biosci 7: d1609-d1623, 2002.
29. D’Angio CT, Maniscalco WM, Ryan RM, Avissar NE, Basavegowda K, Sinkin RA. Vascular endothelial growth factor in pulmonary lavage fluid from premature infants: effects of age and postnatal dexamethasone. Biol Neonate 76: 266–273, 1999.
30. Davis AJ, Jobe AH, Hafner D, Ikegami M. Lung function in premature lambs and rabbits treated with a recombinant SP-C surfactant. Am J Respir Crit Care Med 157: 553–559, 1998.
31. Davis J, Rosenfeld W, Parad R. Improved pulmonary outcome at one year corrected age in premature infants treated with recombinant human superoxide dismutase (Abstract). Pediatr Res 47: 395A, 2000.
32. Davis JM, Penney DP, Notter RH, Metlay L, Dickerson B, Shapiro DL. Lung injury in the neonatal piglet caused by hyperoxia and mechanical ventilation. J Appl Physiol 67: 1007–1012, 1989.
33. Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 100: 24–30, 1997.
34. Debeer A, Sbragia L, Vrancken K, Hendriks A, Roubliova X, Jani J, Naulaers G, Carmeliet P, Deprest J. Antenatal fetal VEGF therapy to promote pulmonary maturation in a preterm rabbit model. Early Hum Dev 86: 99–105, 2010.
35. Delemos RA, Coalson JJ, Gerstmann DR, Kuehl TJ, Null DM Jr. Oxygen toxicity in the premature baboon with hyaline membrane disease. Am Rev Respir Dis 136: 677–682, 1987.
36. Digeronimo RJ, Mustafa SB, Ryan RM, Sternberg ZZ, Ashton DJ, Seidner SR. Mechanical ventilation down-regulates surfactant protein A and keratinocyte growth factor expression in premature rabbits. Pediatr Res 62: 277–282, 2007.
37. Dobkin M, Rozycki H, Gutcher GR, Fisher BJ, Dailey K, Fowler AA. Transforming growth factor-b in hyperoxic newborn lung injury (Abstract). Am J Respir Crit Care Med 149: A545, 1994.
38. Flemmer AW, Jani JC, Bergmann F, Muensterer OJ, Gallot D, Hajek K, Sugawara J, Till H, Deprest JA. Lung tissue mechanics predict lung hypoplasia in a rabbit model for congenital diaphragmatic hernia. Pediatr Pulmonol 42: 505–512, 2007.
39. Frank L. Developmental aspects of experimental pulmonary oxygen toxicity. Free Radic Biol Med 11: 463–494, 1991.
40. Frank L, Bucher JR, Roberts RJ. Oxygen toxicity in neonatal and adult animals of various species. J Appl Physiol 45: 699–704, 1978.
41. Frank L, Groseclose E. Oxygen toxicity in newborn rats: the adverse effects of undernutrition. J Appl Physiol 53: 1248–1255, 1982.
42. Frank L, Groseclose EE. Preparation for birth into an O2-rich environment: the antioxidant enzymes in the developing rabbit lung. Pediatr Res 18: 240–234, 1984.
43. Frank L, Sosenko IR. Prenatal development of lung antioxidant enzymes in four species. J Pediatr 110: 106–110, 1987.
44. Frank L, Sosenko IR. Failure of premature rabbits to increase antioxidant enzymes during hyperoxic exposure: increased susceptibility to pulmonary oxygen toxicity compared with term rabbits. Pediatr Res 29: 292–296, 1991.
45. Gras-Le Guen C, Denis C, Franco-Montoya ML, Jarry A, Delacourt C, Potel G, Bourbon J, Roze JC, Jarreau PH. Antenatal infection in the rabbit impairs post-natal growth and lung alveolarisation. Eur Respir J 32: 1520–1528, 2008.
46. Hastings RH, Ryan RM, D’Angio CT, Holm BA, Patel A, Quintana R, Biederman E, Burton DW, Deftos LJ. Parathyroid hormone-related protein response to hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 282: L1198–L1208, 2002.
47. Holtzman RB, Adler L, Smith LJ, Shamsuddin M, Hunt CE, Hageman JR. Loss of oxygen tolerance in newborn rabbits: relationship to changes in eicosanoid and antioxidant levels. Pediatr Pulmonol 7: 200–208, 1989.
48. Holtzman RB, Zemaitis J, Adler L, Smith LJ, Hunt CE, Hageman JR. Role of eicosanoids in relative oxygen tolerance of newborn rabbits. Prostaglandins 37: 481–491, 1989.
49. Hooper SB, Kitchen MJ, Siew ML, Lewis RA, Fouras A, te Pas AB, Siu KK, Yagi N, Uesugi K, Wallace MJ. Imaging lung aeration and lung liquid clearance at birth using phase contrast X-ray imaging. Clin Exp Pharmacol Physiol 36: 117–125, 2009.
50. Horowitz S, Shapiro DL, Finkelstein JN, Notter RH, Johnston CJ, Quible DJ. Changes in gene expression in hyperoxia-induced neonatal lung injury. Am J Physiol Lung Cell Mol Physiol 258: L107–L111, 1990.
51. Hosford GE, Olson DM. Effects of hyperoxia on VEGF, its receptors, and HIF-2a in the newborn rat lung. Am J Physiol Lung Cell Mol Physiol 285: L161–L168, 2003.
52. Hua S, Zhang X, Zhang S, Xu J, Feng Z. Effects of different ventilation strategies on lung injury in newborn rabbits. Pediatr Pulmonol 47: 1103–1112, 2012.
53. Iliodromiti Z, Zygouris D, Sifakis S, Pappa KI, Tsikouras P, Salakos N, Daniilidis A, Siristatidis C, Vrachnis N. Acute lung injury in preterm fetuses and neonates: mechanisms and molecular pathways. J Matern Fetal Neonatal Med 26: 1696–1704, 2013.
54. Issa A, Lappalainen U, Kleinman M, Bry K, Hallman M. Inhaled nitric oxide decreases hyperoxia-induced surfactant abnormality in preterm rabbits. Pediatr Res 45: 247–254, 1999.
55. Jobe AH. The new bronchopulmonary dysplasia. Curr Opin Pediatr 23: 167–172, 2011.
56. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 46: 641–643, 1999.
57. Josephson MB, Jiao J, Xu S, Hu A, Paranjape C, Grunstein JS, Grumbach Y, Nino G, Kreiger PA, McDonough J, Grunstein MM. IL-13-induced changes in endogenous glucocorticoid metabolism in the lung regulate the proasthmatic response. Am J Physiol Lung Cell Mol Physiol 303: L382–L390, 2012.
58. Kamaruzaman NA, Kardia E, Kamaldin N, Latahir AZ, Yahaya BH. The rabbit as a model for studying lung disease and stem cell therapy. Biomed Res Int 2013: 691830, 2013.
59. Keir S, Page C. The rabbit as a model to study asthma and other lung diseases. Pulm Pharmacol Ther 21: 721–730, 2008.
60. Kertesz NJ, Holtzman RB, Adler L, Hageman JR. Evaluation of a leukotriene receptor antagonist in prevention of hyperoxic lung injury in newborn rabbits. Prostaglandins Leukot Essent Fatty Acids 45: 159–165, 1992.
61. Khan PA, Cloutier M, Piedboeuf B. Tracheal occlusion: a review of obstructing fetal lungs to make them grow and mature. Am J Med Genet C Semin Med Genet 145C: 125–138, 2007.
62. Kikkawa Y, Kaibara M, Motoyama EK, Orzalesi MM, Cook CD. Morphologic development of fetal rabbit lung and its acceleration with cortisol. Am J Pathol 64: 423–442, 1971.
63. Kinsella JP, Parker TA, Davis JM, Abman SH. Superoxide dismutase improves gas exchange and pulmonary hemodynamics in premature lambs. Am J Respir Crit Care Med 172: 745–749, 2005.
64. Kobayashi T, Nitta K, Ganzuka M, Inui S, Grossmann G, Robertson B. Inactivation of exogenous surfactant by pulmonary edema fluid. Pediatr Res 29: 353–356, 1991.
65. Komissarov AA, Florova G, Azghani A, Karandashova S, Kurdowska AK, Idell S. Active a-macroglobulin is a reservoir for urokinase after fibrinolytic therapy in rabbits with tetracycline-induced pleural injury and in human pleural fluids. Am J Physiol Lung Cell Mol Physiol 305: L682–L692, 2013.
66. Komissarov AA, Mazar AP, Koenig K, Kurdowska AK, Idell S. Regulation of intrapleural fibrinolysis by urokinase-alpha-macroglobulin complexes in tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 297: L568–L577, 2009.
67. Kovar J, Sly PD, Willet KE. Postnatal alveolar development of the rabbit. J Appl Physiol 93: 629–635, 2002.
68. Lavoisier AL. Alterations qu’eproube l’air respire. In: Oeuvres de Lavoisier. Paris: Imprimaire Imperiale, 1862–1893, p. 676–687.
69. Lin YJ, Markham NE, Balasubramaniam V, Tang JR, Maxey A, Kinsella JP, Abman SH. Inhaled nitric oxide enhances distal lung growth after exposure to hyperoxia in neonatal rats. Pediatr Res 58: 22–29, 2005.
70. Madurga A, Mizikova I, Ruiz-Camp J, Morty RE. Recent advances in late lung development and the pathogenesis of bronchopulmonary dysplasia. Am J Physiol Lung Cell Mol Physiol 305: L893–L905, 2013.
71. Makar RS, Powers A, Stowell CP. Reducing transfusion-related acute lung injury risk: evidence for and approaches to transfusion-related acute lung injury mitigation. Transfus Med Rev 26: 305–320, 2012.
72. Maniscalco WM, Watkins RH, D’Angio CT, Ryan RM. Hyperoxic injury decreases alveolar epithelial cell expression of vascular endothelial growth factor (VEGF) in neonatal rabbit lung. Am J Respir Cell Mol Biol 16: 557–567, 1997.
73. Maniscalco WM, Watkins RH, Pryhuber GS, Bhatt A, Shea C, Huyck H. Angiogenic factors and alveolar vasculature: development and alterations by injury in very premature baboons. Am J Physiol Lung Cell Mol Physiol 282: L811–L823, 2002.
74. Maniscalco WM, Watkins RH, Roper JM, Staversky R, O’Reilly MA. Hyperoxic ventilated premature baboons have increased p53, oxidant DNA damage and decreased VEGF expression. Pediatr Res 58: 549–556, 2005.
75. Manzano RM, Mascaretti RS, Carrer V, Haddad LB, Fernandes AR, Reyes AM, Rebello CM. A hyperoxic lung injury model in premature rabbits: the influence of different gestational ages and oxygen concentrations. PLoS One 9: e95844, 2014.
76. Martin TR, Frevert CW. Innate immunity in the lungs. Proc Am Thorac Soc 2: 403–411, 2005.
77. Mascaretti RS, Mataloun MM, Dolhnikoff M, Rebello CM. Lung morphometry, collagen and elastin content: changes after hyperoxic exposure in preterm rabbits. Clinics (Sao Paulo) 64: 1099–1104, 2009.
78. Mataloun MM, Leone CR, Mascaretti RS, Dohlnikoff M, Rebello CM. Effect of postnatal malnutrition on hyperoxia-induced newborn lung development. Braz J Med Biol Res 42: 606–613, 2009.
79. McColley SA, Morty RE. Update in pediatric lung disease 20Am J Respir Crit Care Med 188: 293–297, 2013.
80. Meller S, Bhandari V. VEGF levels in humans and animal models with RDS and BPD: temporal relationships. Exp Lung Res 38: 192–203, 2012.
81. Min JH, Codipilly CN, Nasim S, Miller EJ, Ahmed MN. Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression. Respir Res 13: 58, 2012.
82. Miyata R, Bai N, Vincent R, Sin DD, Van Eeden SF. Novel properties of statins: suppression of the systemic and bone marrow responses induced by exposure to ambient particulate matter (PM10) air pollution. Am J Physiol Lung Cell Mol Physiol 303: L492–L499, 2012.
83. Muhlfeld C, Ochs M. Quantitative microscopy of the lung: a problembased approach. Part 2: stereological parameters and study designs in various diseases of the respiratory tract. Am J Physiol Lung Cell Mol Physiol 305: L205–L221, 2013.
84. Nakamura T, Ogawa Y. Prophylactic effects of recombinant human superoxide dismutase in neonatal lung injury induced by the intratracheal instillation of endotoxin in piglets. Biol Neonate 80: 163–168, 2001.
85. Nishijima K, Shukunami K, Yoshinari H, Takahashi J, Maeda H, Takagi H, Kotsuji F. Interactions among pulmonary surfactant, vernix caseosa, and intestinal enterocytes: intra-amniotic administration of fluorescently liposomes to pregnant rabbits. Am J Physiol Lung Cell Mol Physiol 303: L208–L214, 2012.
86. Nitta K, Kobayashi T. Impairment of surfactant activity and ventilation by proteins in lung edema fluid. Respir Physiol 95: 43–51, 1994.
87. O’Reilly M, Thebaud B. The promise of stem cells in bronchopulmonary dysplasia. Semin Perinatol 37: 79–84, 2013.
88. Oba K, Yamashita H, Waragai A, Kawano T. NF-kappaB in the lungs of premature rabbits during mechanical ventilation— comparison between conventional mechanical ventilation (CMV) and high-frequency oscillation (HFO). Pediatr Pulmonol 42: 446–451, 2007.
89. Ochs M, Muhlfeld C. Quantitative microscopy of the lung: a problembased approach. Part 1: basic principles of lung stereology. Am J Physiol Lung Cell Mol Physiol 305: L15–L22, 2013.
90. Ogawa J, Saito H. Hyaline membrane in the lung of premature newborn mammals. Study on the etiological factors. Nagoya Med J 7: 44–49, 1961.
91. Perveen S, Patel H, Arif A, Younis S, Codipilly CN, Ahmed M. Role of EC-SOD overexpression in preserving pulmonary angiogenesis inhibited by oxidative stress. PLoS One 7: e51945, 2012.
92. Pinkerton KE, Joad JP. The mammalian respiratory system and critical windows of exposure for children’s health. Environ Health Perspect 108, Suppl 3: 457–462, 2000.
93. Polak MJ, Knight ME, Andresen TL, DeSena C. Effects of hyperoxia and beta-adrenergic stimulation on pulmonary surfactant in neonatal rabbits. Exp Lung Res 18: 373–384, 1992.
94. Rey-Parra GJ, Archer SL, Bland RD, Albertine KH, Carlton DP, Cho SC, Kirby B, Haromy A, Eaton F, Wu X, Thébaud B. Blunted hypoxic pulmonary vasoconstriction in experimental neonatal chronic lung disease. Am J Respir Crit Care Med 178: 399–406, 2008.
95. Richter J, Toelen J, Vanoirbeek J, Kakigano A, Dekoninck P, Verbeken E, Deprest J. Functional assessment of hyperoxia-induced lung injury after preterm birth in the rabbit. Am J Physiol Lung Cell Mol Physiol 306: L277–L283, 2014.
96. Roan E, Waters CM. What do we know about mechanical strain in lung alveoli? Am J Physiol Lung Cell Mol Physiol 301: L625–L635, 2011.
97. Robbins CG, Horowitz S, Merritt TA, Kheiter A, Tierney J, Narula P, Davis JM. Recombinant human superoxide dismutase reduces lung injury caused by inhaled nitric oxide and hyperoxia. Am J Physiol Lung Cell Mol Physiol 272: L903–L907, 1997.
98. Rogers LK, Valentine CJ, Pennell M, Velten M, Britt RD, Dingess K, Zhao X, Welty SE, Tipple TE. Maternal docosahexaenoic acid supplementation decreases lung inflammation in hyperoxia-exposed newborn mice. J Nutr 141: 214–222, 2011.
99. Rosenfeld W, Evans H, Concepcion L, Jhaveri R, Schaeffer H, Friedman A. Prevention of bronchopulmonary dysplasia by administration of bovine superoxide dismutase in preterm infants with respiratory distress syndrome. J Pediatr 105: 781–785, 1984.
100. Rosenfeld WN, Davis JM, Parton L, Richter SE, Price A, Flaster E, Kassem N. Safety and pharmacokinetics of recombinant human superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics 97: 811–817, 1996.
101. Saugstad OD. Oxygen and oxidative stress in bronchopulmonary dysplasia. J Perinat Med 38: 571–577, 2010.
102. Shah M, Bry K, Hallman M. Protective effect of exogenous transferrin against hyperoxia: a study on premature rabbits. Pediatr Pulmonol 24: 429–437, 1997.
103. Shanklin DR. On the pulmonary toxicity of oxygen. I. The relationship of oxygen content to the effect of oxygen on the lung. Lab Invest 21: 439–448, 1969.
104. Sherman MP, Condiotti R. Hyperoxia damages phagocytic defenses of neonatal rabbit lung. J Appl Physiol 62: 684–690, 1987.
105. Sherman MP, Evans MJ, Campbell LA. Prevention of pulmonary alveolar macrophage proliferation in newborn rabbits by hyperoxia. J Pediatr 112: 782–786, 1988.
106. Singhaus CJ, Utidjian LH, Akins RE, Miller TL, Shaffer TH, Touch SM. Growth and development in a heliox incubator environment: a long-term safety study. Neonatology 91: 28–35, 2007.
107. Sosenko IR, Chen Y, Price LT, Frank L. Failure of premature rabbits to increase lung antioxidant enzyme activities after hyperoxic exposure: antioxidant enzyme gene expression and pharmacologic intervention with endotoxin and dexamethasone. Pediatr Res 37: 469–475, 1995.
108. Suresh GK, Davis JM, Soll RF. Superoxide dismutase for preventing chronic lung disease in mechanically ventilated preterm infants. Cochrane Database Syst Rev: CD001968, 2001.
109. Thurlbeck WM. Postnatal growth and development of the lung. Am Rev Respir Dis 111: 803–844, 1975.
110. Varughese R, Nayak JL, LoMonaco M, O’Reilly MA, Ryan RM, D’Angio CT. Effects of hyperoxia on tumor necrosis factor alpha and Grobeta expression in newborn rabbit lungs. Lung 181: 335–346, 2003.
111. Veness-Meehan KA, Bottone FG Jr, Stiles AD. Effects of retinoic acid on airspace development and lung collagen in hyperoxia-exposed newborn rats. Pediatr Res 48: 434–444, 2000.
112. Veness-Meehan KA, Cheng ER, Mercier CE, Blixt SL, Johnston CJ, Watkins RH, Horowitz S. Cell-specific alterations in expression of hyperoxia-induced mRNAs of lung. Am J Respir Cell Mol Biol 5: 516–521, 1991.
113. Veness-Meehan KA, Rhodes DN, Stiles AD. Temporal and spatial expression of biglycan in chronic oxygen-induced lung injury. Am J Respir Cell Mol Biol 11: 509–516, 1994.
114. Waheed S, D’Angio CT, Wagner CL, Madtes DK, Finkelstein JN, Paxhia A, Ryan RM. Transforming growth factor alpha (TGFa) is increased during hyperoxia and fibrosis. Exp Lung Res 28: 361–72, 2002.
115. Walther FJ, David-Cu R, Lopez SL. Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits. Am J Physiol Lung Cell Mol Physiol 269: L613–L617, 1995.
116. Walther FJ, Mehta EI, Padbury JF. Lung CuZn-superoxide dismutase and catalase gene expression in premature rabbits treated intratracheally with antioxidant-surfactant liposomes. Biochem Mol Med 59: 169–173, 1996.
117. Wang YW, Liou NH, Cherng JH, Chang SJ, Ma KH, Fu E, Liu JC, Dai NT. siRNA-targeting transforming growth factor-beta type I receptor reduces wound scarring and extracellular matrix deposition of scar tissue. J Invest Dermatol 134: 2016–2025, 2014.
118. Ward JA, Roberts RJ. Effect of hyperoxia on phosphatidylcholine synthesis, secretion, uptake and stability in the newborn rabbit lung. Biochim Biophys Acta 796: 42–50, 1984.
119. Ward JA, Roberts RJ. Hyperoxia effects on pulmonary pressure: volume characteristics and lavage surfactant phospholipid in the newborn rabbit. Biol Neonate 46: 139–148, 1984.
120. Ward JA, Roberts RJ. Vitamin E inhibition of the effects of hyperoxia on the pulmonary surfactant system of the newborn rabbit. Pediatr Res 18: 329–34, 1984.
121. Watkins RH, D’Angio CT, Ryan RM, Patel A, Maniscalco WM. Differential expression of VEGF mRNA splice variants in newborn and adult hyperoxic lung injury. Am J Physiol Lung Cell Mol Physiol 276: L858–L867, 1999.
122. Wender DF, Thulin GE, Smith GJ, Warshaw JB. Vitamin E affects lung biochemical and morphologic response to hyperoxia in the newborn rabbit. Pediatr Res 15: 262–268, 1981.
123. Wispe JR, Knight M, Roberts RJ. Lipid peroxidation in newborn rabbits: effects of oxygen, lipid emulsion, and vitamin E. Pediatr Res 20: 505–510, 1986.
124. Wu J, Yamamoto H, Gratacos E, Ge X, Verbeken E, Sueishi K, Hashimoto S, Vanamo K, Lerut T, Deprest J. Lung development following diaphragmatic hernia in the fetal rabbit. Hum Reprod 15: 2483–2488, 2000.
125. Zagariya A, Sierzputovska M, Navale S, Vidyasagar D. Role of meconium and hypoxia in meconium aspiration-induced lung injury in neonatal rabbits. Mediators Inflamm 2010: 204831, 2010.
126. Zoetis T, Hurtt ME. Species comparison of lung development. Birth Defects Res B Dev Reprod Toxicol 68: 121–124, 2003.